Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2025-12-30 @ 2:18 AM
Study NCT ID:
NCT03963232
Status:
COMPLETED
Last Update Posted:
2023-03-28
First Post:
2019-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Galcanezumab (LY2951742) in Participants With Episodic Migraine
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-30
Start Date Type:
ACTUAL
Primary Completion Date:
2021-07-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-11
Completion Date Type:
ACTUAL
First Submit Date:
2019-05-16
First Submit QC Date:
None
Study First Post Date:
2019-05-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-06-29
Results First Submit QC Date:
None
Results First Post Date:
2022-08-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-01
Last Update Post Date:
2023-03-28
Last Update Post Date Type:
ACTUAL